Thiogenesis Therapeutics, Corp. (TTIPF) Corporate Subsidiaries
Access SEC EDGAR filings, financial statements, 10-K, 10-Q, 8-K reports, auditor information, and financial intelligence for Thiogenesis Therapeutics, Corp. (TTIPF).
Ticker: TTIPF
CIK: 1877778
Exchange: OTC
Fiscal Year End: 02/28
State: A6
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PCAOB Registered Accounting Firm
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| D | 2026-06-09 | — | D Filing | 0001062993-26-003123 | View SEC Doc Filr Page |
| D | 2025-08-08 | — | D Filing | 0001062993-25-013902 | View SEC Doc Filr Page |
| D | 2023-12-20 | — | D Filing | 0001062993-23-022931 | View SEC Doc Filr Page |
| D | 2022-11-25 | — | D Filing | 0001062993-22-022769 | View SEC Doc Filr Page |
| D | 2021-08-11 | — | D Filing | 0001062993-21-007309 | View SEC Doc Filr Page |